24 April 2025FeaturesEuropeAgathe Michel-de Cazotte & Ben Chapman

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

Following the Unified Patent Court’s recent Meril v Edwards decision, Agathe Michel-de Cazotte & Ben Chapman of Carpmaels & Ransford examine the court’s treatment of obviousness to date.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
15 April 2025   A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say Eoin Martyn and Hannah Garvey of Taylor Wessing.
Europe
8 April 2025   The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject Meril’s latest attempt to invalidate Edwards’ patent.
Unified Patent Court
16 July 2024   UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.

More on this story

Europe
15 April 2025   A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say Eoin Martyn and Hannah Garvey of Taylor Wessing.
Europe
8 April 2025   The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject Meril’s latest attempt to invalidate Edwards’ patent.
Unified Patent Court
16 July 2024   UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.

More on this story

Europe
15 April 2025   A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say Eoin Martyn and Hannah Garvey of Taylor Wessing.
Europe
8 April 2025   The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject Meril’s latest attempt to invalidate Edwards’ patent.
Unified Patent Court
16 July 2024   UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.